Local Institution

Utrecht 3584CX

0 studies enrolling now · 11 studies all time

What they study most

Advanced Cancer, Advanced Gastric Cancer, Advanced Non-small Cell Lung Cancer, Atrial Fibrillation, Atrial Flutter, Diabetes Mellitus II, Gastric/Esophageal Adenocarcinoma, HIV Infections, Hepatitis C Virus, Kidney Transplantation, Lymphoma. Non-Hodgkin, Melanoma

Studies at this site

• A Study to Test Combination Treatments in Participants With Advanced Gastric Cancer — Completed
• An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3) — Completed
• An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread — Completed
• Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139) — Completed
• Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Observation Compared With Adjuvant Nivolumab in Treatment-Naive High-risk Melanoma Participants — Withdrawn before enrolling
• A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based — Completed
• Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia — Completed
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types — Completed
• BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada — Completed
• Dose Ranging Study With LT, Monotherapy, PPAR — Completed